Oncoclinicas do Brasil
Oncoclínicas do Brasil Serviços Médicos S.A., together with its subsidiaries, provides oncology, hematology, radiotherapy, and genomics healthcare services in Latin America. The company offers treatment services, including radiotherapy, hormone therapy, immunotherapy, port-a-cath, palliative care, target therapy, breast cancer hormone therapy, bone marrow transplant, non-oncological infusions, ch… Read more
Market Cap & Net Worth: Oncoclinicas do Brasil (ONCO3)
Oncoclinicas do Brasil (SA:ONCO3) has a market capitalization of $266.89 Million (R$1.63 Billion) as of March 18, 2026. Listed on the SA stock exchange, this Brazil-based company holds position #28137 globally and #247 in its home market, demonstrating a -13.95% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oncoclinicas do Brasil's stock price R$1.85 by its total outstanding shares 878588947 (878.59 Million).
Oncoclinicas do Brasil Market Cap History: 2021 to 2026
Oncoclinicas do Brasil's market capitalization history from 2021 to 2026. Data shows change from $1.62 Billion to $266.89 Million (-39.86% CAGR).
Oncoclinicas do Brasil Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oncoclinicas do Brasil's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.05x
Oncoclinicas do Brasil's market cap is 0.05 times its annual revenue
0.38x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $1.62 Billion | $2.70 Billion | -$46.90 Million | 0.60x | N/A |
| 2022 | $869.93 Million | $4.09 Billion | $46.26 Million | 0.21x | 18.81x |
| 2023 | $1.88 Billion | $5.49 Billion | $223.62 Million | 0.34x | 8.39x |
| 2024 | $337.58 Million | $6.23 Billion | -$646.19 Million | 0.05x | N/A |
Competitor Companies of ONCO3 by Market Capitalization
Companies near Oncoclinicas do Brasil in the global market cap rankings as of March 18, 2026.
Key companies related to Oncoclinicas do Brasil by market ranking:
- HCA Holdings Inc (NYSE:HCA): Ranked #271 globally with a market cap of $77.08 Billion USD.
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1068 globally with a market cap of $18.32 Billion USD.
- Fresenius SE & Co. KGaA (PINK:FSNUF): Ranked #1139 globally with a market cap of $16.86 Billion USD.
- Brookdale Senior Living Inc (NYSE:BKDT): Ranked #1227 globally with a market cap of $15.19 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #271 | HCA Holdings Inc | NYSE:HCA | $77.08 Billion | $509.87 |
| #1068 | Tenet Healthcare Corporation | NYSE:THC | $18.32 Billion | $211.64 |
| #1139 | Fresenius SE & Co. KGaA | PINK:FSNUF | $16.86 Billion | $41.01 |
| #1227 | Brookdale Senior Living Inc | NYSE:BKDT | $15.19 Billion | $77.60 |
Oncoclinicas do Brasil Historical Marketcap From 2021 to 2026
Between 2021 and today, Oncoclinicas do Brasil's market cap moved from $1.62 Billion to $ 266.89 Million, with a yearly change of -39.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | R$266.89 Million | -31.73% |
| 2025 | R$390.96 Million | +15.81% |
| 2024 | R$337.58 Million | -82.00% |
| 2023 | R$1.88 Billion | +115.59% |
| 2022 | R$869.93 Million | -46.40% |
| 2021 | R$1.62 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Oncoclinicas do Brasil was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $266.89 Million USD |
| MoneyControl | $266.89 Million USD |
| MarketWatch | $266.89 Million USD |
| marketcap.company | $266.89 Million USD |
| Reuters | $266.89 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.